Multiple Myeloma: The Cancer of Bone Marrow

Multiple Myeloma is a type of cancer that starts in the plasma cells of the bone marrow. These plasma cells are responsible for producing antibodies that help the body fight infections. However, in multiple myeloma, these plasma cells become cancerous and grow out of control, leading to the production of abnormal proteins that can cause damage to the bones, kidneys, and other organs.

This type of cancer can weaken the bones, leading to symptoms such as bone pain, fractures, and an increased risk of infections. Other symptoms of multiple myeloma may include fatigue, weakness, weight loss, and frequent infections. The exact cause of multiple myeloma is unknown, but certain risk factors, such as age, family history, and exposure to radiation or certain chemicals, may increase the likelihood of developing the disease.

Diagnosis of multiple myeloma usually involves a combination of physical exams, blood tests, imaging tests, and a bone marrow biopsy. Treatment options for multiple myeloma may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplantation. The goal of treatment is to control the growth of cancer cells, manage symptoms, and improve the quality of life for patients.